What is Gender Medicine?
Every cell is sexed and every individual is gendered. Sex and gender influence the incidence, cause and progression of disease.
Sex and gender also affect the access and outcomes of medical treatments, and consumption of health care in general.
The increased understanding of how sex and gender affect our health and disease processes will ultimately improve health for everyone.
Aims of the CfGM
The overall aim of CfG is to support research and education towards innovation in health care via promotion and implementation of sex and gender analysis (“gender dimension”).
These activities spark new knowledge, strengthen the quality and competitiveness of scientific innovation and lead to the optimal exploitation of knowledge and expertise to improve health care for women, men, boys, and girls, and gender diverse people.
Being first established in Europe our Centre serves as a leading example and strives elaboration of already existing and new collaborations worldwide (EuGenMed, The International Society for Gender Medicine, Mayo Clinic, The Organization for the Study of Sex Differences, Stanford University Gendered Innovations).
Profile is multidisciplinary and includes cardiovascular and regenerative medicine, inflammatory diseases; disturbances in hormonal and endocrine environment and reproductive health, chronic kidney disease, neurological disorders and global health, as well as in the fields of drug utilization and pharmacokinetics, and developmental origins of health and disease.
Sex and gender interconnects all areas of medical preclinical and clinical research, uniquely setting KI Centre for Gender Medicine to collaborate broadly across disciplines, namelly in strategic partnerships together with: industry, health care providers and patient organizations.
Our working platform is interdisciplinary and based in 4 pillars (4 Is) torwards innovative thinking:
1. Infrastructure/resources: to foster human and knowledge capital to insure center’s sustainability and fundraise for continuous support of strategic/selected areas of research, education and science communication.
2. Integration: to endorse the integration of sex/gender analysis in medical science and health care via improving structural attitudes/changes within our research and educational systems.
3. Innovation: to stimulate innovative methods, discoveries, treatments in science and medicine.
4. Impact: to insure that new research outcomes using sex/gender perspective have measurable and tangible impact on policies, products, services and systems that improve health to everybody.
Members of the Board
|Karin Schenck-Gustafsson||Chair, Senior Professor, KI|
|Jan-Olov Höög||Member, Professor, KI|
|Carol Tishelman||Member, Professor, KI|
|Anna Nergårdh||Member, Chief Medical, SLL|
|Anders Ekbom||Member, Senior Professor, KI|
|Beth Friberg||Member, Chairman, Forex Bank|
|Torgny Wännström||Member, MD h.c.|
|Anders Carlsten||Member, Docent, Läkemedelsverket|
|Karin Schenck-Gustafsson||Head of Centre, Senior Professor, KI|
|Kristina Broliden||Professor, Prefekt, Institutionen för medicin, Solna|
|Helena Berggren||Finance manager, Deputy head of administration, MEDS, KI|
More information on Gender Medicine
Interview with Karolina Kublickiene
Review article "Why are sex and gender important to basic physiology and translational and individualized medicine?", from Virginia Miller.
Review article "Sex and gender differences in health", EMBO Reports from Vera Regitz-Zagrosek.
For a popular science approach check : TEDxBeaconStreet video with David Page: "Why sex really matters" and TED video with Paula Johnsson: "His and hers … healthcare".